This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

Early Registration Deadline:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12-15 May 2025
Congress Center HamburgHamburg, Germany

Mr Simon Fradin
Senior Manager / Lab Head Upstream Process Development, Biopharmaceutical Product Development at Fresenius Kabi
Speaker

Profile

Simon has built his experience through the Upstream process development for different targets (mAbs, complex macro-molecules as well as gene therapy vectors) using different expression systems (CHO/human/insect cells).

Throughout his different roles, Simon has contributed to Upstream process development from discovery phase to scale-up for manufacturing at clinical development phase.

Simon is the Upstream process development lab head for the Biosimilars unit of Fresenius Kabi Biopharma. Amongst his responsibilities, Simon oversees the technological development applied on the Upstream processes. In combination with the scientific expertise, this continuous improvement approach supports the state-of-the-art development of future biosimilar candidates of Fresenius Kabi Biopharma.

Agenda Sessions

  • Bridging the Gap: Overcoming Challenges in Upstream Process Scale-Up from Lab to Pilot Plant

    14:20